MedPath

Partners in Care With Semi-Structured Support Group

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
Registration Number
NCT02144909
Lead Sponsor
University of Hawaii
Brief Summary

The investigators are conducting a feasibility study using a randomized controlled trial (RCT) design in which participants will receive the Partners in Care (PIC) diabetes self-management intervention and then be randomized to either semi-structured social support or a standard follow-up control group. Participants in the support groups will receive a culturally-tailored, semi-structured social support program delivered in a community setting by trained community peer educators and other health professionals (e.g., pharmacist). The investigators believe that the addition of a semi-structured social support component as a supplement to an evidence-based diabetes self-management intervention will improve diabetes self-care maintenance.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
65
Inclusion Criteria
  • Self-reported Native Hawaiian, Filipino, or other Pacific Islander ethnic background
  • Adults age >18 years of age
  • English-speaking
  • Physician-diagnosed type 2 diabetes
  • Baseline hemoglobin A1c >8%
Exclusion Criteria
  • Survival less than 6 months
  • Planning to move out of the community during the intervention study period
  • Pregnancy
  • Any co-morbid condition (physical and mental disabilities) that would prevent the individual from participating in the intervention protocol (i.e., major psychiatric illness)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change from Baseline hemoglobin a1c at 3 months and at 6 monthsbaseline, 3 months, 6 months
Change from Baseline diabetes management functioning as measured by the Problem Areas in Diabetes questionnaire at 3 months and 6 monthsbaseline, 3 months, 6 months

The PAID is a 20-item instrument that assesses the physical and social functioning of patients as well as their perceived level of mental and emotional well-being specific to living with diabetes.

Secondary Outcome Measures
NameTimeMethod
Change from Baseline weight in kg at 3 months and 6 monthsbaseline, 3 months, 6 months
Change from Baseline blood pressure at 3 months and 6 monthsbaseline, 3 months, 6 months
Change from Baseline Total Cholesterol (including HDL and LDL) and triglycerides at 3 months and 6 monthsbaseline, 3 months, 6 months

Total Cholesterol (including HDL and LDL) and triglycerides will be measured with the Cholestech LDX analyzer

Trial Locations

Locations (3)

Kula no na Po'e Hawai'i

🇺🇸

Honolulu, Hawaii, United States

Ke Ola Mamao

🇺🇸

Honolulu, Hawaii, United States

Kokua Kalihi Valley

🇺🇸

Honolulu, Hawaii, United States

Kula no na Po'e Hawai'i
🇺🇸Honolulu, Hawaii, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.